Dr. Norma Iris Gonzalez, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 218 Brooks St. Blgd. 21, Rodriguez Army Health Clinic, Fort Buchanan, PR 00934 Phone: 787-707-4393 |
News Archive
A pilot study at The University of Texas Health Science Center at Houston (UTHealth) will assess the use of deep brain stimulation (DBS) in the medial forebrain bundle of the brain for treatment-resistant depression.
NBC's "The Biggest Loser" and The Active Network, Inc.'s flagship website Active.com today announced the launch of The Biggest Loser Event Challenge, powered by Active.com, a series of nationwide 5K and one mile events designed to inspire Americans of all fitness levels to get moving with others.
Imagine you're a hockey goalie, and two opposing players are breaking in alone on you, passing the puck back and forth. You're aware of the linesman skating in on your left, but pay him no mind. Your focus is on the puck and the two approaching players. As the action unfolds, how is your brain processing this intense moment of "multi-tasking"? Are you splitting your focus of attention into multiple "spotlights?" Are you using one "spotlight" and switching between objects very quickly? Or are you "zooming out" the spotlight and taking it all in at once?
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
› Verified 4 days ago